Aspira Pathlab & Diagnostics Ltd — Important, 07-01-2026: Company Update

Aspira Pathlab & Diagnostics has submitted a certificate from its Registrar & Share Transfer Agent confirming the efficient processing of share dematerialisation for the quarter ended December 31, 2025. This certificate verifies that all securities received for dematerialisation were properly confirmed to depositories and subsequently listed on stock exchanges. Furthermore, security certificates were duly cancelled and registered in the depositories' names within the required timeframe. This process ensures accurate and timely updates to shareholder records, enhancing transparency and investor confidence in the company's share management.